Screener
Eton Pharmaceuticals, Inc. ETON Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | Three months ended / March 31, 2026 | Three months ended / March 31, 2025 |
|---|---|---|
| Net cash used in investing activities | (15,075) | — |
| Cash flows from financing activities | ||
| Proceeds from stock option exercises | 1,389 | 394 |
| Net cash from financing activities | 1,389 | 394 |
| Change in cash and cash equivalents | (6,281) | 2,484 |
| Cash and cash equivalents at beginning of period | 25,942 | 14,936 |
| Cash and cash equivalents at end of period | $19,661 | $17,420 |
| Supplemental disclosures of cash flow information |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s financing cash flow?
- Eton Pharmaceuticals, Inc. (ETON) reported financing cash flow of $1.39M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Eton Pharmaceuticals, Inc.'s financing cash flow increased by 252.5% year-over-year, from $394K to $1.39M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Eton Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude